The Monarch Select Subsector Index ETF (MSSS) has an implied analyst target price of $40.79 per unit, reflecting a potential upside of 14.72% from its current trading price of $35.56. This analysis, conducted by ETF Channel, evaluates the ETF against average 12-month target prices for its underlying holdings.
Key underlying holdings contributing to MSSS’s outlook include the SPDR S&P Biotech ETF (XBI) with a recent price of $154.24, suggesting a possible upside of 37.66%; the SPDR S&P Pharmaceuticals ETF (XPH) at $68.60, with a 27.30% upside; and the iShares U.S. Medical Devices ETF (IHI) priced at $50.51, indicating a 17.79% upside. Together, these three holdings comprise 30.43% of MSSS.
Investors are encouraged to consider whether analysts’ target prices are justified or optimistic, as high targets may indicate future price downgrades if they’re based on outdated information.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
